Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study
Open Access
- 25 July 2015
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 13 (1) , 1-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progressionScientific Reports, 2013
- BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular VesiclesMolecular Therapy Nucleic Acids, 2013
- Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathwayMolecular Biology of the Cell, 2012
- Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5Journal of Biological Chemistry, 2011
- Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progressionMolecular Cancer, 2010
- Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral SignalingCancer Research, 2010
- Role of Focal Adhesion Kinase Ser-732 Phosphorylation in Centrosome Function during MitosisJournal of Biological Chemistry, 2009
- Cdk5 is essential for adult hippocampal neurogenesisProceedings of the National Academy of Sciences, 2008
- Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasionProceedings of the National Academy of Sciences, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007